Education
About Us
Working with TipRanks
Follow Us
Scandinavian ChemoTech AB Class B (SE:CMOTEC.B)
:CMOTEC.B
RESEARCH TOOLSreports
CMOTEC.B Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr0.88 - kr3.00
Previous CloseN/A
Volume128.00
Average Volume (3M)45.89K
Market Cap
kr34.20M
Enterprise ValueN/A
Total Cash (Recent Filing)kr949.00K
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta0.31
Next Earnings
May 14, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.62
Shares Outstanding21,692,312
10 Day Avg. Volume41,381
30 Day Avg. Volume45,890
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Scandinavian ChemoTech AB Class B News
---
CMOTEC.B FAQ
What was Scandinavian ChemoTech AB Class B’s price range in the past 12 months?
Scandinavian ChemoTech AB Class B lowest stock price was kr0.88 and its highest was kr3.00 in the past 12 months.
What is Scandinavian ChemoTech AB Class B’s market cap?
Scandinavian ChemoTech AB Class B’s market cap is kr34.20M.
When is Scandinavian ChemoTech AB Class B’s upcoming earnings report date?
Scandinavian ChemoTech AB Class B’s upcoming earnings report date is May 14, 2025 which is in 18 days.
How were Scandinavian ChemoTech AB Class B’s earnings last quarter?
Scandinavian ChemoTech AB Class B released its earnings results on Mar 04, 2025. The company reported -kr0.136 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.136.
Is Scandinavian ChemoTech AB Class B overvalued?
According to Wall Street analysts Scandinavian ChemoTech AB Class B’s price is currently Overvalued.
Does Scandinavian ChemoTech AB Class B pay dividends?
Scandinavian ChemoTech AB Class B does not currently pay dividends.
What is Scandinavian ChemoTech AB Class B’s EPS estimate?
Scandinavian ChemoTech AB Class B’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scandinavian ChemoTech AB Class B have?
Scandinavian ChemoTech AB Class B has 21,692,312 shares outstanding.
What happened to Scandinavian ChemoTech AB Class B’s price movement after its last earnings report?
Scandinavian ChemoTech AB Class B reported an EPS of -kr0.136 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.932%.
Which hedge fund is a major shareholder of Scandinavian ChemoTech AB Class B?
Currently, no hedge funds are holding shares in SE:CMOTEC.B
---
Company Description
Scandinavian ChemoTech AB Class B
Scandinavian ChemoTech AB is a Sweden based clinical development company. It is engaged in research on pain management and therapy for prostate cancer.
---
Technical Analysis
Diagonal Bio AB
―
Stayble Therapeutics AB
―
Lipigon Pharmaceuticals AB
―
―
QuiaPEG Pharmaceuticals Holding AB
―
---